Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Board changes

30 May 2024 12:00

RNS Number : 4436Q
Xaar PLC
30 May 2024
 

30 May 2024

 

Xaar plc

 

Board changes

 

Xaar plc ("Xaar" or "the Group" or "the Company"), the leading inkjet printing technology group, is pleased to announce the appointment of Dr Inken Braunschmidt as Independent Non-Executive Director.

 

Inken joins the Board with effect from 1 June 2024 and on appointment will be a member of the Audit, Remuneration and Nomination Committees.

 

As previously disclosed, Alison Littley had notified the Board of her intention to step down as a Non-Executive Director of the Company during 2024. It is now confirmed that Alison will leave the Board on 30 June 2024. Inken will be appointed as Chair of Remuneration Committee on 1 July 2024.

 

Richard Amos, Non-Executive Director, will replace Alison Littley as the Company's Senior Independent Director on 1 July 2024.

 

Inken Braunschmidt is currently a non-executive director of James Fisher and Sons plc, listed on the London Stock Exchange, and Chair of its Remuneration Committee as well as a member of the Audit and Nomination Committees. She was Chief Innovation and Digital Officer and member of the Executive Board of Halma plc until 2023. Prior to joining Halma plc in 2017, Inken spent 13 years at RWE AG, the German energy giant, and its renewables subsidiary innogy SE, where she held various international leadership roles focusing on strategy, innovation, digital transformation and change management. Inken studied Business Administration, Innovation & Technology Management at Kiel University and did her PhD thesis in Technology Management. Inken is member of the Digital Programme Board of the Royal Academy of Engineering.

 

 

Andrew Herbert, Chairman, commented:

 

"We are delighted to welcome Inken to the Board and her expertise and experience in international electronic engineering and digital innovation and transformation are very relevant to the opportunities and challenges that face Xaar. I would like to thank Alison for her contribution and commitment to the Board of Xaar as a director since 2020 and wish her the very best for the future."

 

The Company confirms there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to the appointment of Inken Braunschmidt.

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

 

Teneo

Giles Kernick

Olivia Lucas

+44 (0) 207 353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAURAWRSAUVORR
Date   Source Headline
30th Nov 20123:32 pmRNSTotal Voting Rights
22nd Oct 20127:00 amRNSDirector/PDMR Shareholding
18th Oct 20127:00 amRNSIMS and Corporate Open Day
1st Oct 20122:58 pmRNSTotal Voting Rights
26th Sep 20127:00 amRNSTR-1
24th Sep 20127:00 amRNSXAAR'S PARTNERS LAUNCH XAAR 1001 GS12 PRINTERS
3rd Sep 20123:19 pmRNSTotal Voting Rights
16th Aug 20127:00 amRNSInterim Results
1st Aug 201210:02 amRNSTotal Voting Rights
24th Jul 20127:00 amRNSXaar Joins Make It In Great Britain Exhibition
19th Jul 20127:00 amRNSTrading Statement
18th Jul 20129:34 amRNSHolding(s) in Company
13th Jul 20124:41 pmRNSHolding(s) in Company
3rd Jul 20124:23 pmRNSAdditional Listing
29th Jun 20126:20 pmRNSBlocklisting Interim Review
28th Jun 20127:00 amRNSPositive Response To New P3 Product Launch
27th Jun 201210:04 amRNSHolding(s) in Company
26th Jun 201210:11 amRNSDirector/PDMR Shareholding
12th Jun 20125:39 pmRNSHolding(s) in Company
11th Jun 20124:31 pmRNSDirector/PDMR Shareholding
7th Jun 201210:10 amRNSHolding(s) in Company
1st Jun 20129:24 amRNSDirector Declaration
31st May 20124:54 pmRNSTotal Voting Rights
22nd May 20124:54 pmRNSResult of AGM
17th May 20121:21 pmRNSHolding(s) in Company
4th May 20127:00 amRNSNotice of AGM
3rd May 20124:35 pmRNSHolding(s) in Company
2nd May 20123:12 pmRNSGrant of Options
1st May 20129:38 amRNSTotal Voting Rights
25th Apr 20125:21 pmRNSHolding(s) in Company
25th Apr 201211:26 amRNSDirector/ PDMR Shareholding
23rd Apr 20127:00 amRNSDirector/PDMR Shareholding
19th Apr 20127:00 amRNSAnnual Information Update
19th Apr 20127:00 amRNSInterim Management Statement
16th Apr 20126:13 pmRNSDirector/PDMR Shareholding - Replacement
13th Apr 20128:54 amRNSDirector/PDMR Shareholding
5th Apr 20123:25 pmRNSDirector/PDMR Shareholding
3rd Apr 20127:00 amRNSIssue of Options
30th Mar 20125:39 pmRNSTotal Voting Rights
19th Mar 20127:00 amRNSFinal Results
15th Mar 20127:00 amRNSHolding(s) in Company
9th Mar 20124:00 pmRNSHolding(s) in Company
1st Mar 20128:30 amRNSHolding(s) in Company
29th Feb 20128:48 amRNSHolding(s) in Company
28th Feb 20127:00 amRNSChange of 2011 Results Announcement Date
20th Feb 20125:33 pmRNSHolding(s) in Company
20th Feb 20125:24 pmRNSHolding(s) in Company
24th Jan 20126:05 pmRNSHolding(s) in Company
24th Jan 20127:00 amRNSChina Staff Changes
19th Jan 20127:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.